3FL-28883-28156 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-10-20
Dose 1 — Pfizer-BioNTech
Co-administered: Do not remember
2021-10-28
Registered in v-safe
2021-10-28
Dose 2 — Pfizer-BioNTech
Co-administered: yes
2021-10-28
Survey response — day 0, dose 2
MedDRA: No adverse event — Feeling: Good · Site: Swelling · Fever · Chills · Be unable to do your normal daily activities

Free text: Bien

MedDRA releases: 2024-11 · check-in free text available
2021-10-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-11-01
Survey response — days 1–6 daily, dose 2
MedDRA: No adverse event — Feeling: Good

Free text: No

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-10-20	Pfizer-BioNTech	Do not remember
2	2021-10-28	Pfizer-BioNTech	Yes

Free text

Release 10 — day 0, dose 2

2021-10-28

Systemic reaction (other): Bien

Release 10 — days 1–6 daily, dose 2

2021-11-01

Systemic reaction (other): No

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	No adverse event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release